Objective: To develop a method for immunohistochemical staining of three different T lymphocyte antigens (CD4 or CD8, CD57 and TCRβ) on the same tissue section and to determine whether tissues have been infiltrated with T lymphocytes expressing these markers. Study Design: Commercially available antibodies were tested for immunohistochemical usefulness in a dye-based conventional single-immunostaining method after antigen retrieval on paraffin-embedded human lymph nodes. We searched for the combination of antibodies that could detect T lymphocyte antigens on the same section without any cross-reactivity and that have fluorescent signals robust enough to overcome paraffin autofluorescence. Results: Application of the antigen retrieval technique and the Sudan black B quenching technique enabled staining of paraffin-embedded tissue sections with fluorescent-labeled secondary antibodies. The combination of primary and secondary antibodies that could simultaneously detect the T lymphocyte antigens CD4 or CD8, CD57 and TCRβ in histochemical analysis of a paraffin-embedded human lymph node section was established, and was successfully applied to a human tissue section infiltrated with T lymphocytes that express these markers. Conclusion: The antibodies listed here would be helpful for histopathologists who wish to investigate T lymphocytes in the paraffin-embedded sections that have accumulated in pathology labs throughout the world.

Keywords:
Antigen retrieval technique, CD4, CD8, CD57, Immunohistochemistry, TCRβ, Paraffin section
1.
Zola H, Swart B, Banham A, Barry S, Beare A, Bensussan A, Boumsell L, Buckley CD, Bühring HJ, Clark G, Engel P, Fox D, Jin BQ, Macardle PJ, Malavasi F, Mason D, Stockinger H, Yang X: CD molecules 2006 – human cell differentiation molecules. J Immunol Methods 2007;319:1–5.
2.
Shan-Rong S, Richard JC, Clive RT: Antigen retrieval immunohistochemistry – past, present, and future. J Histochem Cytochem 1997;45:327–344.
3.
Ino H: Application of antigen retrieval by heating for double-label fluorescent immunohistochemistry with identical species-derived primary antibodies. J Histochem Cytochem 2004;52:1209–1217.
4.
Viegas MS, Martins TC, Seco F, do Carmo A: An improved and cost-effective methodology for the reduction of autofluorescence in direct immunofluorescence studies on formalin-fixed paraffin-embedded tissues. Eur J Histochem 2007;51:59–66.
5.
Takayama E, Koike Y, Ohkawa T, Majima T, Fukasawa M, Shinomiya N, Yamaguchi T, Konishi M, Hiraide H, Tadakuma T, Seki S: Functional and Vbeta repertoire characterization of human CD8+ T-cell subsets with natural killer cell markers, CD56+ CD57- T cells, CD56+ CD57+ T cells and CD56- CD57+ T cells. Immunology 2003;108:211–219.
6.
Leroy E, Calvo CF, Divine M, Gourdin MF, Baujean F, Ben Aribia MH, Mishal Z, Vernant JP, Farcet JP, Senik A: Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation. J Immunol 1986;137:2180–2189.
7.
Gorochov G, Debré P, Leblond V, Sadat-Sowti B, Sigaux F, Autran B: Oligoclonal expansion of CD8+ CD57+ T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. Blood 1994;83:587–595.
8.
Sadat-Sowti B, Debré P, Mollet L, Quint L, Hadida F, Leblond V, Bismuth G, Autran B: An inhibitor of cytotoxic functions produced by CD8+CD57+ T lymphocytes from patients suffering from AIDS and immunosuppressed bone marrow recipients. Eur J Immunol 1994;24:2882–2888.
9.
Dupuy d’Angeac A, Monier S, Jorgensen C, Gao Q, Travaglio-Encinoza A, Bologna C, Combe B, Sany J, Rème T: Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis: correlation with duration of disease. Arthritis Rheum 1993;36:608–612.
10.
Watanabe H, Weerasinghe A, Miyaji C, Sekikawa H, Toyabe S, Mannor MK, Morshed SR, Halder RC, Kobayashi J, Toma H, Sato Y, Iwai K, Matsuoka H, Abo T: Expansion of unconventional T cells with natural killer markers in malaria patients. Parasitol Int 2003;52:61–70.
11.
Akagi J, Baba H: Prognostic value of CD57(+) T lymphocytes in the peripheral blood of patients with advanced gastric cancer. Int J Clin Oncol 2008;13:528–535.
12.
Dolstra H, Preijers F, Van de Wiel-van Kemenade E, Schattenberg A, Galama J, de Witte T: Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection. Br J Haematol 1995;90:300–307.
13.
Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA: The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol 2007;81:7759–7765.
14.
Chochi K, Ichikura T, Majima T, Kawabata T, Matsumoto A, Sugasawa H, Kawarabayashi N, Takayama E, Hiraide H, Seki S, Mochizuki H: The increase of CD57+ T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer. Oncol Rep 2003;10:1443–1448.
15.
Alaverdi N: Monoclonal antibodies to mouse cell-surface antigens. Curr Protoc Immunol 2002;appendix 4B.
16.
Bratthauer GL: The peroxidase-antiperoxidase (PAP) method and other all-immunologic detection methods. Methods Mol Biol 2010;588:243–255.
17.
Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741–748.
18.
Baschong W, Suetterlin R, Laeng RH: Control of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM). J Histochem Cytochem 2001;49:1565–1572.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.